Personalized vs Standardized Self-Management Training for Colorectal Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two types of self-management training for individuals who have had colorectal cancer (cancer of the colon or rectum) in the past five years. One group receives personalized self-management training tailored to their specific needs, while the other group receives a standardized program. The goal is to determine which type of training better helps patients maintain healthy habits. Suitable candidates are those interested in improving lifestyle-related risk factors, such as diet or exercise. Participants must communicate in English and be willing to work on at least one lifestyle change. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance self-management strategies for future patients.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, long-term hormonal or biologic therapy is acceptable, so you may be able to continue those treatments.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that specific safety information is not yet available for the self-management training being tested in this trial for colorectal cancer patients. However, as this is a training program rather than a medication or medical procedure, the risk of serious side effects is generally low. Self-management training typically includes advice on lifestyle and health habits, which are generally safe.
Although detailed safety data is not available, it is important to note that this trial is in an early stage. Early-stage trials often focus on safety, so researchers will closely monitor any major risks. Participants can expect the training to be manageable, as it is designed to help, not harm.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how personalized approaches to self-management training might benefit individuals with colorectal cancer. Unlike traditional standardized programs, the RISE-PSMT (Personalized Self-Management Training) tailors strategies to each person's unique needs, potentially leading to better outcomes and improved quality of life. By focusing on personalization, this approach might empower patients to manage their health more effectively compared to one-size-fits-all methods. The trial could reveal important insights into the effectiveness and benefits of customizing self-care strategies for cancer patients.
What evidence suggests that this trial's treatments could be effective for colorectal cancer?
This trial will compare Personalized Self-Management Training (PSMT) with Standardized Self-Management Training (SSMT) for individuals with colorectal cancer. Research has shown that PSMT can be more effective than standard methods. One study found that self-management programs, which teach personal skills, improved patients' quality of life and helped them manage cancer challenges. These programs also led to better recovery and adherence to healthy habits. Another study found that PSMT increased adherence to healthy behavior recommendations compared to standard training. This suggests that personalized approaches may offer extra benefits in managing colorectal cancer.13567
Who Is on the Research Team?
Alix G. Sleight, PhD, OTD, MPH, OTR/L
Principal Investigator
University of Southern California
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've had Stage I-III colorectal cancer in the last year, are willing to improve at least one lifestyle risk factor like diet or exercise, and can speak English. They should have moderate to low adherence to healthy behaviors but can't be planning major cancer treatments within 6 months or have stage IV cancers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 6-week self-management training program, either personalized (PSMT) or standardized (SSMT), conducted by licensed occupational therapists
Follow-up
Participants are monitored for adherence to healthy behavior recommendations and quality of life assessments
What Are the Treatments Tested in This Trial?
Interventions
- Personalized Self-Management Training
- Standardized Self-Management Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arash Asher, MD
Lead Sponsor
University of Southern California
Lead Sponsor
Alix G. Sleight, PhD
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator